Analysts Set Oscar Health, Inc. (NYSE:OSCR) PT at $16.88

Shares of Oscar Health, Inc. (NYSE:OSCR) have been assigned a consensus rating of “Hold” from the ten brokerages that are currently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $16.8750.

Several brokerages have weighed in on OSCR. Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a report on Saturday, February 14th. Piper Sandler upgraded shares of Oscar Health from a “neutral” rating to an “overweight” rating and raised their price objective for the company from $13.00 to $25.00 in a research report on Tuesday, November 25th. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price for the company in a report on Thursday, February 12th. UBS Group reiterated a “neutral” rating and issued a $15.00 price target on shares of Oscar Health in a research note on Wednesday, February 11th. Finally, Barclays set a $18.00 price objective on Oscar Health and gave the company an “equal weight” rating in a research report on Monday, January 5th.

Oscar Health Trading Down 3.5%

NYSE:OSCR opened at $13.25 on Monday. The company has a market cap of $3.51 billion, a PE ratio of -7.61 and a beta of 1.90. The company has a current ratio of 0.96, a quick ratio of 0.92 and a debt-to-equity ratio of 0.44. The company has a 50 day simple moving average of $14.95 and a two-hundred day simple moving average of $16.68. Oscar Health has a 12 month low of $11.20 and a 12 month high of $23.80.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing the consensus estimate of ($0.92) by ($0.32). The business had revenue of $2.76 billion during the quarter, compared to the consensus estimate of $3.12 billion. Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.Oscar Health’s revenue for the quarter was up 17.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.62) EPS. Research analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.

Insiders Place Their Bets

In other Oscar Health news, insider Mario Schlosser sold 76,962 shares of the company’s stock in a transaction that occurred on Tuesday, January 6th. The stock was sold at an average price of $17.01, for a total value of $1,309,123.62. Following the completion of the transaction, the insider directly owned 350,180 shares in the company, valued at $5,956,561.80. This represents a 18.02% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Richard Scott Blackley sold 25,135 shares of Oscar Health stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $416,989.65. Following the sale, the chief financial officer owned 1,351,034 shares in the company, valued at approximately $22,413,654.06. The trade was a 1.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 197,125 shares of company stock valued at $3,265,300. 24.39% of the stock is owned by company insiders.

Institutional Investors Weigh In On Oscar Health

Several large investors have recently made changes to their positions in OSCR. Farther Finance Advisors LLC lifted its position in shares of Oscar Health by 4,420.7% in the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock worth $25,000 after buying an additional 1,282 shares in the last quarter. Jones Financial Companies Lllp increased its stake in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the last quarter. Strs Ohio purchased a new stake in shares of Oscar Health during the 1st quarter worth approximately $30,000. Atlantic Union Bankshares Corp bought a new position in shares of Oscar Health during the 2nd quarter valued at approximately $33,000. Finally, Fifth Third Bancorp grew its holdings in shares of Oscar Health by 148.7% in the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after purchasing an additional 1,413 shares in the last quarter. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.